期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
The impact of nucleos(t)ide analog therapy in hepatitis B on the incidence of hepatocellular carcinoma: an update including recent literature findings 被引量:1
1
作者 Walid SAyoub francis dailey +1 位作者 Paul Martin Patricia DJones 《Hepatoma Research》 2017年第12期302-308,共7页
Worldwide, hepatocellular carcinoma (HCC) is a significant cause of morbidity and mortality. In men, it is the fifth most common cancer and seventh most common in women;HCC is the second highest cause of cancer-relate... Worldwide, hepatocellular carcinoma (HCC) is a significant cause of morbidity and mortality. In men, it is the fifth most common cancer and seventh most common in women;HCC is the second highest cause of cancer-related death worldwide. It is less prevalent in the USA and Northern Europe and more prevalent in Eastern and South-Eastern Asia. Over 700,000 cases are diagnosed each year - half of which occur in China - and result in roughly the same number of deaths per year. HCC significantly impairs quality of life and is associated with great costs to society. It is estimated that half of the deaths from HCC are associated with hepatitis B virus (HBV). Fortunately, HBV vaccination and antiviral therapy have shown excellent efficacy in decreasing the incidence of HCC. We will discuss the relationship of HBV to HCC, address available treatments for HBV and the impact of treatment on the development of HCC. 展开更多
关键词 Liver cancer HEPATOCELLULAR carcinoma hepatitis B nucleos(t)ides ENTECAVIR TENOFOVIR LAMIVUDINE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部